Antibody Cocktails Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-03-09　·　151 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 2.2 Bn
2033 年預估規模: USD 7.3 Bn
年複合成長率 CAGR: 17.7%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-03-09頁數 151報告編號 CMI4950

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Antibody Cocktails Market, By Type (Monovalent Antibody and Polyvalent Antibody), By Indication (COVID-19, Cancer, HIV, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

An antibody, also called immunoglobulin, is a protective protein produced by the immune system of the body in response to the presence of a foreign substance, called an antigen. Antigens are a wide range of substances that include disease-causing organisms and toxic materials such as insect venom, bacteria, or viruses. An antibody cocktail is basically a combination or cocktail of two different antibodies. The rationale behind combining two antibodies in a cocktail approach is to minimize mutational viral escape. Market Dynamics The increasing adoption of inorganic strategies such as partnerships and agreements by key players in the market is expected to drive the market growth during the forecast period. For instance, in May 2021, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Cipla Inc., a multinational pharmaceutical company, entered into a strategic partnership by which F. Hoffmann-La Roche Ltd., will import its antibody cocktail (Casirivimab and Imdevimab) medication into India, where it will then be marketed and distributed by the Cipla’s distribution network. Moreover, in August 2020, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Regeneron Pharmaceuticals Inc., a biotechnology company, announced that they had agreed to develop, manufacture, and distribute REGN-COV2, Regeneron’s investigational antiviral antibody cocktail, to people around the globe. This collaboration is expected to increase the supply of REGN-COV2 by at least three and a half times the current capacity, with the potential for even further expansion. As a part of this agreement, Regeneron will be responsible for distributing REGN-COV2 in the U.S. and Roche will distribute it outside the U.S., as a part of this agreement. Key features of the study • This report provides an in-depth analysis of the global antibody cocktails market, and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global antibody cocktails market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Cipla Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Zydus Cadila, AstraZeneca, Aridis Pharmaceuticals Inc., Immunome Inc., Celltrion Healthcare Co., Ltd., and Eli Lilly and Company • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global antibody cocktails market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibody cocktails market Market Segmentation • By Type o Monovalent Antibody o Polyvalent Antibody • By Indication o COVID-19 o Cancer o HIV o Others • By Distribution Channel o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • By Regional Insights o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Cipla Inc. o Hoffmann-La Roche Ltd o Regeneron Pharmaceuticals Inc. o Zydus Cadila o AstraZeneca o Aridis Pharmaceuticals Inc. o Immunome Inc. o Celltrion Healthcare Co.,Ltd. o Eli Lilly and Company.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Type  Market Snapshot, By Indication  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Pipeline Analysis o Regulatory Scenario o Reimbursement Scenario o Product Launches o PEST Analysis 4. Global Antibody Cocktails Market, By Type, 2026 – 2033, (USD Bn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Monovalent antibody  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Polyvalent antibody  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Antibody Cocktails Market, By Indication, 2026 – 2033, (USD Bn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o COVID-19  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Cancer  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o HIV  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Antibody Cocktails Market, By Distribution Channel, 2026 – 2033, (USD Bn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Hospital Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Retail Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Online Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Antibody Cocktails Market, By Region, 2026 – 2033, (USD Bn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2021–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o UK o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Cipla Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o F. Hoffmann-La Roche Ltd  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Regeneron Pharmaceuticals Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Zydus Cadila  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o AstraZeneca  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Aridis Pharmaceuticals Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o AstraZene Immunome Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Celltrion Healthcare Co., Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Eli Lilly and Company  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us

提及公司

Cipla Inc.Hoffmann-La Roche LtdRegeneron Pharmaceuticals Inc.Zydus CadilaAstraZenecaAridis Pharmaceuticals Inc.Immunome Inc.Celltrion Healthcare Co.,Ltd.Eli Lilly and Company.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們